Home » Market News » DirectorsTalk Highlights » Study Finds Childhood Trauma Can Worsen Disease Activity for Adults With Lupus
Immupharma Plc

Study Finds Childhood Trauma Can Worsen Disease Activity for Adults With Lupus

If you’ve long suspected your traumatic childhood impacted your health later in life, a new study published in the journal Arthritis Care & Research found compelling evidence there’s a connection between experiencing childhood trauma or adversity and lupus.

Systemic lupus erythematosus (SLE) is an autoimmune condition that causes your immune system to attack healthy tissues and organs in your body. Because any organ system can be affected, lupus can cause a wide range of symptoms. Common lupus symptoms include chronic pain, fatigue, a butterfly-shaped facial rash and hair loss.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.